Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
GKOS
GKOS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GKOS News
Glaukos Set to Announce Q4 Earnings Expectations
3h ago
seekingalpha
Glaukos Director Stapley Sells Shares Worth $1.9 Million
Jan 31 2026
NASDAQ.COM
Glaukos Director Sells 15,000 Shares for $1.9 Million
Jan 31 2026
Fool
Glaukos iDose TR Receives FDA Labeling Approval
Jan 28 2026
seekingalpha
Glaukos Receives FDA Approval for iDose TR Re-Administration
Jan 28 2026
Newsfilter
Glaukos Receives FDA Approval for iDose TR Re-Administration
Jan 28 2026
Yahoo Finance
S&P 500 Index Falls 0.53% as Tech Stocks Weigh Down Market
Jan 15 2026
NASDAQ.COM
S&P 500, Dow, and Nasdaq Decline Amid Rising Geopolitical Risks
Jan 14 2026
NASDAQ.COM
S&P 500, Dow, and Nasdaq Decline; Nasdaq Hits One-Week Low
Jan 14 2026
NASDAQ.COM
Glaukos (GKOS) Q4 Sales Miss Expectations, Shares Drop 12%
Jan 14 2026
seekingalpha
Glaukos Corp (GKOS) Projects FY25 Sales of $507 Million, Shares Drop 12.1%
Jan 14 2026
Benzinga
S&P 500 Futures Decline in Pre-Market Session; Glaukos and Fortinet Underperform
Jan 14 2026
Barron's
Gelteq Ltd Reports 22% Bioavailability Increase in Cannabinoid Oral Gel, Shares Surge 50.1%
Jan 14 2026
Benzinga
Movers: Bank of America, Wells Fargo, Citigroup, Tesla, Nvidia, Intel, and Others
Jan 14 2026
Barron's
Movers: Bank of America, Wells Fargo, Citigroup, Tesla, Rivian, Intel, and Others
Jan 14 2026
Barron's
Movers: Bank of America, Wells Fargo, Citigroup, Tesla, Rivian, Nvidia, Intel, and Others
Jan 14 2026
Barron's
Show More News
